|Articles|February 11, 2008

FDA's crackdown on bio-identical hormones sparks controversy

Pharmacists are up in arms over the warning FDA has issued to seven compounding pharmacies about bioidentical hormone replacement therapy.

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.


Latest CME